Literature DB >> 6765956

Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5.

S Yoshinoya, R M Pope.   

Abstract

Employing five radioimmunoassays for immune complexes, the sera of 45 acute and 27 postacute follow-up sera from patients with acute rheumatic fever were examined. All patients experienced actue polyarthritis. Complexes were detected in 89% of acute-phase sera by one assay, 51% by two, 29% by three, and 7% by four. Immune complex values decreased significantly at followup, although some abnormalities persisted. There was no correlation between extra-articular manifestations and the occurrence of circulating immune complexes. Those positive for HLA-B5 demonstrated a significantly more pronounced immune response as measured by circulating immune complexes. The data indicate that circulating immune complexes occur frequently in adults with acute rheumatic fever. The relative frequency of immune complexes detected by multiple techniques in B5-positive, compared with B5-negative, patients suggests a genetic basis for the development of immune complexes in these patiemts.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6765956      PMCID: PMC371348          DOI: 10.1172/JCI109643

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Antibody titers in acute rheumatic fever.

Authors:  L W WANNAMAKER; E M AYOUB
Journal:  Circulation       Date:  1960-04       Impact factor: 29.690

2.  SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE.

Authors:  E E Fischel; R H Pauli; J Lesh
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

3.  Parallel studies of HLA antigens in patients with rheumatic heart disease and scleritis: comparisons with three control populations.

Authors:  V C Joysey; J H Roger; F Ashworth; W Bullman; B L Hazleman; S M Lachmann; P G Watson
Journal:  J Rheumatol Suppl       Date:  1977

Review 4.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

5.  Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance.

Authors:  J B Zabriskie; K C Hsu; B C Seegal
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

6.  Quantitation of acute and chronic serum sickness in the rabbit.

Authors:  C B Wilson; F J Dixon
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Precipitating antibody to group A streptococcal polysaccharide in humans.

Authors:  R A Zimmerman; A H Auernheimer; A Taranta
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

8.  Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.

Authors:  H S Luthra; F C McDuffie; G G Hunder; E A Samayoa
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

9.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

10.  Association of HL-A 5 and immune responsiveness in vitro to streptococcal antigens.

Authors:  L J Greenberg; E D Gray; E J Yunis
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  14 in total

1.  The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.

Authors:  T Wada; I Ezaki; M Shingu; S Nonaka; E Ohtsuka; M Yasuda; M Nobunaga
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

2.  TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children.

Authors:  Afig Berdeli; Handan Ak Celik; Ruhi Ozyürek; Buket Dogrusoz; Hikmet Hakan Aydin
Journal:  J Mol Med (Berl)       Date:  2005-06-21       Impact factor: 4.599

Review 3.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 4.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 5.  Immunopathogenesis of rheumatic fever and rheumatic heart disease-current concepts.

Authors:  K S Reddy; P S Rao; M L Bhatia
Journal:  Indian J Pediatr       Date:  1982 Nov-Dec       Impact factor: 1.967

6.  Dissociation of IgG aggregates at low pH.

Authors:  R D Soltis; D Hasz
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

7.  Antibodies against proteins of streptococcal hyaluronate synthase bind to human fibroblasts and are present in patients with rheumatic fever.

Authors:  S Prehm; C Herrington; V Nickel; W Völker; N I Briko; E I Blinnikova; A Schmiedel; P Prehm
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

8.  Immunopathology of acute rheumatic fever and rheumatic heart disease. The demonstration of Coxsackie group B viral antigen in the myocardium.

Authors:  B Pongpanich; S Boonpucknavig; C Wasi; P Tanphaichitr; V Boonpucknavig
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

9.  Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.

Authors:  S Yoshinoya; S McDuffy; D Alarcon-Segovia; R M Pope
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

10.  Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders.

Authors:  R M Pope; S Yoshinoya; S J McDuffy
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.